• About
  • Subscribe
  • Advertise
  • Contact
Monday, January 19, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

MDFA launches Australia’s first comprehensive AMD support service

by Staff Writer
July 9, 2024
in Diabetic eye disease, Eye disease, Geographic Atrophy, Macular disease - AMD, Macular edema, Neovascular AMD, News, Ophthalmic organisations
Reading Time: 3 mins read
A A
Eye Connect

The response to the MDFA's launch of the Eye Connect service has been positive. Image: MDFA.

Share on FacebookShare on Twitter

Macular Disease Foundation Australia (MDFA) has launched Eye Connect, a comprehensive support service for people living with macular disease and described as the first of its kind in Australia.

Of the estimated 1.9 million Australians affected by the disease, studies have shown only 56% of patients recall receiving a clear diagnosis, including the name of their condition.

Additionally, 58% of patients were unable to recall receiving any lifestyle modification advice from their eyecare professional.

MDFA responded with Eye Connect, which enables people to access free, evidence-based support in between appointments with their eyecare professional.

Eye Connect is currently available to people living with any stage of age-related macular degeneration (AMD).

It has been developed based on insights from a neovascular AMD pilot program and research involving people living with macular disease, carers, ophthalmologists and optometrists. The peak body said the service will be expanded to support other macular conditions as well.

MDFA has released a video to provide eyecare professionals with an understanding of how the peak body can support their patients after they leave the clinic.

Eye Connect offers a range of tailored support in three key areas:

  • Health information: patients are provided with evidence-based information about macular disease, and non-clinical support services to help them confidently manage their condition.
  • Practical advice: this includes tips and guidance on things like nutrition for healthy eyes, immediate care after their appointments, daily living with reduced or low vision, and transport advice.
  • Emotional support: For some, a diagnosis of macular disease – or living with an eye condition – can be difficult. The Eye Connect team can help patients manage some of their concerns about diagnosis and treatment. Eye Connect can also connect patients to peer support, including trained volunteers and other people also living with macular disease.

MDFA CEO Dr Kathy Chapman, said: “We know that people with macular disease want to connect with more practical and emotional support to help them manage their condition when they’re at home.

“Supporting eyecare professionals to deliver better health outcomes for patients with macular disease is a key priority for Macular Disease Foundation Australia. We have every confidence that Eye Connect will help drive this forward by complementing the information people receive in a clinical setting.”

With figures showing between 300,000 and 400,000 Australians affected by diabetic retinopathy, MDFA said supporting people with diabetic eye disease will be a major focus in the expansion of the Eye Connect service.

“The Eye Connect service will provide a valuable supplement to the information that clinicians give their patients with macular disease,” said Associate Professor Alex Hunyor, MDFA Medical Committee chair.

“Offering support that is tailored to the individual patient is a really practical addition to the services already provided by the Foundation.”

Health professionals can refer patients to the new Eye Connect service by visiting https://www.mdfoundation.com.au/health-professional/refer-to-eyeconnect/, via Oculo or by calling Macular Disease Foundation Australia on 1800 111 709. Patients can also self-refer via the foundation’s website or over the phone.

More reading 

Macular disease report 2024

Evolving GA landscape prompts RANZCO AMD referral pathway update

Turning our attention to age-related macular degeneration – Specsavers

Related Posts

IOLs were stored on the International Space Station and exposed to space conditions for six months. Image: Lemdah/stock.adobe.com.

Intraocular lenses sent to space in first-of-its-kind research project

by Staff Writer
January 19, 2026

A research collaboration between the John A. Moran Eye Center’s Intermountain Ocular Research Center (IORC) and cataract surgeon Dr Morgan...

Marcolin is the owner of a number of luxury eyewear brands. Image: Marcolin.

VSP Vision acquires global eyewear company Marcolin

by Staff Writer
January 19, 2026

American firm VSP Vision has completed the acquisition of global eyewear designer and manufacturer Marcolin from PAI Partners and other...

The study concluded that clinicians should be aware of how cognitive limitations can lead to a reliance on "decisional shortcuts" that might bias decision-making. Image: rh2010/stock.adobe.com

Study supports rethink of IOP threshold in glaucoma treatment

by Staff Writer
January 16, 2026

New research has revealed that despite an evolving clinical understanding of glaucoma, many ophthalmologists continue to rely on the historical...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited